Hemocompatibility of poly(ε-caprolactone) lipid-core nanocapsules stabilized with polysorbate 80-lecithin and uncoated or coated with chitosan

International Journal of Pharmaceutics

Volumn 426, Issue 1-2, 2012, Pages 271-279

  Bender, Eduardo A ^a   Adorne, Márcia D ^a   Colomé, Letícia M ^a   Abdalla, Dulcinéia S P ^b   Guterres, Sílvia S ^a   Pohlmann, Adriana R ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chitosan; Hemocompatibility; Lecithin; Lipid core nanocapsules; Polymeric nanoparticles; Polysorbate 80

Indexed keywords

CHITOSAN; LIPID; NANOCAPSULE; NANOCOATING; PHOSPHATIDYLCHOLINE; POLYCAPROLACTONE; BIOMATERIAL; DRUG CARRIER; POLYESTER; POLYSORBATE;

ARTICLE; BIOCOMPATIBILITY; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD COMPATIBILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ERYTHROCYTE MEMBRANE; HEMOLYSIS; HUMAN; HUMAN CELL; HYDRODYNAMICS; IN VITRO STUDY; LASER DIFFRACTION; LIGHT SCATTERING; NANOTECHNOLOGY; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTHROMBIN TIME; STATIC ELECTRICITY; THROMBOCYTE AGGREGATION; THROMBOPLASTIN TIME; ZETA POTENTIAL; CHEMISTRY; DRUG EFFECT; LIGHT; MATERIALS TESTING; METHODOLOGY; PARTIAL THROMBOPLASTIN TIME; PHARMACEUTICS; RADIATION SCATTERING;

BIOCOMPATIBLE MATERIALS; BLOOD COAGULATION; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; DRUG CARRIERS; DRUG COMPOUNDING; ERYTHROCYTE MEMBRANE; HEMOLYSIS; HUMANS; LECITHINS; LIGHT; LIPIDS; MATERIALS TESTING; NANOCAPSULES; NANOTECHNOLOGY; PARTIAL THROMBOPLASTIN TIME; PARTICLE SIZE; PLATELET AGGREGATION; POLYESTERS; POLYSORBATES; PROTHROMBIN TIME; SCATTERING, RADIATION; TECHNOLOGY, PHARMACEUTICAL;

EID: 84857791331     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.01.051     Document Type: Article

References (39)

1. Y. Aktas, M. Yemisci, K. Andrieux, R.N. Gursoy, M.J. Alonso, E. Fernandez-Megia, R. Novoa-Carballal, E. Quinoa, R. Riguera, M.F. Sargon, H.H. Celik, A.S. Demir, A.A. Hincal, T. Dalkara, Y. Capan, and P. Couvreur Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26 Bioconjugate Chem. 16 2005 1503 1511 (Pubitemid 41681517)
2. M.P. Alves, A.L. Scarrone, M. Santos, A.R. Pohlmann, and S.S. Guterres Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers Int. J. Pharm. 341 2007 215 220 (Pubitemid 47088101)
3. P. Baldrick The safety of chitosan as a pharmaceutical excipient Regul. Toxicol. Pharm. 56 2010 290 299
4. A. Bernardi, A. Zilberstein, E. Jager, M.M. Campos, F.B. Morrone, J.B. Calixto, A.R. Pohlmann, S.S. Guterres, and A.M.O. Battastini Effects of indomethacin-loaded nanocapsules in experimental models of inflammation in rats Br. J. Pharmacol. 158 2009 1104 1111
5. Brazil. ANVISA - Agência Nacional de Vigilância Sanitária. Resolution RDC no. 57, 2010 December 16. Retrieved from http://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2010/res0057-16-12-2010.html.
6. J.D. Byrne, T. Betancourt, and L. Brannon-Peppas Active targeting schemes for nanoparticle systems in cancer therapeutics Adv. Drug Deliv. Rev. 60 2008 1615 1626
7. G.Q. Cai, H.L. Jiang, Z.J. Chen, K.H. Tu, L.Q. Wang, and K.J. Zhu Synthesis, characterization and self-assemble behavior of chitosan-O- poly(epsilon-caprolactone) Eur. Polym. J. 45 2009 1674 1680
8. V.B. Cattani, L.A. Fiel, A. Jager, E. Jager, L.M. Colome, F. Uchoa, V. Stefani, T. Dalla Costa, S.S. Guterres, and A.R. Pohlmann Lipid-core nanocapsules restrained the indomethacin ethyl ester hydrolysis in the gastrointestinal lumen and wall acting as mucoadhesive reservoirs Eur. J. Pharm. Sci. 39 2010 116 124
9. C. Celia, E. Trapasso, D. Cosco, D. Paolino, and M. Fresta Turbiscan Lab (R) Expert analysis of the stability of ethosomes (R) and ultradeformable liposomes containing a bilayer fluidizing agent Colloids Surf. B 72 2009 155 160
10. E. Cenni, D. Granchi, S. Avnet, C. Fotia, M. Salerno, D. Micieli, M.G. Sarpietro, R. Pignatello, F. Castelli, and N. Baldini Biocompatibility of poly(d,l-lactide-co-glycolide) nanoparticles conjugated with alendronate Biomaterials 29 2008 1400 1411
11. L. Cruz, L.U. Soares, T. Dalla Costa, G. Mezzalira, N.P. da Silveira, S.S. Guterres, and A.R. Pohlmann Diffusion and mathematical modeling of release profiles from nanocarriers Int. J. Pharm. 313 2006 198 205
12. Z.R. Cui, and R.J. Mumper Chitosan-based nanoparticles for topical genetic immunization J. Control. Release 75 2001 409 419 (Pubitemid 32727270)
13. M.A. Dobrovolskaia, A.K. Patri, J.W. Zheng, J.D. Clogston, N. Ayub, P. Aggarwal, B.W. Neun, J.B. Hall, and S.E. McNeil Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles Nanomedicine: NBM 5 2009 106 117
14. H. Fessi, F. Puisieux, J.P. Devissaguet, N. Ammoury, and S. Benita Nanocapsule formation by interfacial polymer deposition following solvent displacement Int. J. Pharm. 55 1989 R1 R4 (Pubitemid 19247505)
15. V. Filipe, A. Hawe, and W. Jiskoot Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates Pharm. Res. 27 2010 796 810
16. R.L. Frozza, A. Bernardi, K. Paese, J.B. Hoppe, T. da Silva, A.M.O. Battastini, A.R. Pohlmann, S.S. Guterres, and C. Salbego Characterization of trans-resveratrol-loaded lipid-core nanocapsules and tissue distribution studies in rats J. Biomed. Nanotechnol. 6 2010 694 703
17. J.A. Gallego-Urrea, J. Tuoriniemi, T. Pallander, and M. Hassellov Measurements of nanoparticle number concentrations and size distributions in contrasting aquatic environments using nanoparticle tracking analysis Environ. Chem. 7 2009 67 81
18. C.F. Hogman, K. Hedlund, and Y. Sahlestrom Red-Cell preservation in protein-poor media. Protection against in vitro hemolysis Vox Sang. 41 1981 274 281 (Pubitemid 12245909)
19. N.T. Huynh, C. Passirani, P. Saulnier, and J.P. Benoit Lipid nanocapsules: a new platform for nanomedicine Int. J. Pharm. 379 2009 201 209
20. A. Jager, V. Stefani, S.S. Guterres, and A.R. Pohlmann Physico-chemical characterization of nanocapsule polymeric wall using fluorescent benzazole probes Int. J. Pharm. 338 2007 297 305 (Pubitemid 46777236)
21. E. Jager, C.G. Venturini, F.S. Poletto, L.M. Colome, J.P.U. Pohlmann, A. Bernardi, A.M.O. Battastini, S.S. Guterres, and A.R. Pohlmann Sustained release from lipid-core nanocapsules by varying the core viscosity and the particle surface area J. Biomed. Nanotechnol. 5 2009 130 140
22. 8 Superlattices Microstruct. 43 2008 315 323
23. C.F. Jones, and D.W. Grainger In vitro assessments of nanomaterial toxicity Adv. Drug Deliv. Rev. 61 2009 438 456
24. M.N. Jones Surfactants in membrane solubilisation Int. J. Pharm. 177 1999 137 159 (Pubitemid 29073411)
25. J.M. Koziara, J.J. Oh, W.S. Akers, S.P. Ferraris, and R.J. Mumper Blood compatibility of cetyl alcohol/polysorbate-based nanoparticles Pharm. Res. 22 2005 1821 1828 (Pubitemid 41504335)
26. K. Letchford, R. Liggins, K.M. Wasan, and H. Burt In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles Eur. J. Pharm. Biopharm. 71 2009 196 206
27. A. Mayer, M. Vadon, B. Rinner, A. Novak, R. Wintersteiger, and E. Frohlich The role of nanoparticle size in hemocompatibility Toxicology 258 2009 139 147
28. O. Mengual, G. Meunier, I. Cayre, K. Puech, and P. Snabre TURBISCAN MA 2000: multiple light scattering measurement for concentrated emulsion and suspension instability analysis Talanta 50 1999 445 456
29. G.P.A.K. Michanetzis, Y.F. Missirlis, and S.G. Antimisiaris Haemocompatibility of nanosized drug delivery systems: has it been adequately considered? J. Biomed. Nanotechnol. 4 2008 218 233
30. V.C.F. Mosqueira, P. Legrand, H. Pinto-Alphandary, F. Puisieux, and G. Barratt Poly(d,l-lactide) nanocapsules prepared by a solvent displacement process: influence of the composition on physicochemical and structural properties J. Pharm. Sci. 89 2000 614 626
31. N. Nafee, M. Schneider, U.F. Schaefer, and C.M. Lehr Relevance of the colloidal stability of chitosan/PLGA nanoparticles on their cytotoxicity profile Int. J. Pharm. 381 2009 130 139
32. F.A. Oyarzun-Ampuero, M. Garcia-Fuentes, D. Torres, and M.J. Alonso Chitosan-coated lipid nanocarriers for therapeutic applications J. Drug Deliv. Sci. Tech. 20 2010 259 265
33. C. Prego, P. Paolicelli, B. Diaz, S. Vicente, A. Sanchez, A. Gonzalez-Fernandez, and M. Jose Alonso Chitosan-based nanoparticles for improving immunization against hepatitis B infection Vaccine 28 2010 2607 2614
34. M. Skotak, A.P. Leonov, G. Larsen, S. Noriega, and A. Subramanian Biocompatible and biodegradable ultrafine fibrillar scaffold materials for tissue engineering by facile grafting of l-lactide onto chitosan Biomacromolecules 9 2008 1902 1908
35. P. Vermette, and L. Meagher Interactions of phospholipid- and poly(ethylene glycol)-modified surfaces with biological systems: relation to physico-chemical properties and mechanisms Colloids Surf. B 28 2003 153 198 (Pubitemid 36287176)
36. N. von Ahsen, P. Lewczuk, E. Schutz, M. Oellerich, and H. Ehrenreich Prothrombin activity and concentration in healthy subjects with and without the prothrombin G20210A mutation Thromb. Res. 99 2000 549 556 (Pubitemid 30642734)
37. B. Wang, C. He, C. Tang, and C. Yin Effects of hydrophobic and hydrophilic modifications on gene delivery of amphiphilic chitosan based nanocarriers Biomaterials 32 2011 4630 4638
38. D. Xu, K. Wu, Q.H. Zhang, H.Y. Hu, K. Xi, Q.M. Chen, X.H. Yu, J.N. Chen, and X.D. Jia Synthesis and biocompatibility of anionic polyurethane nanoparticles coated with adsorbed chitosan Polymer 51 2010 1926 1933
39. B.J. Zern, H.H. Chu, A.O. Osunkoya, J. Gao, and Y.D.A. Wang Biocompatible arginine-based polycation Adv. Funct. Mater. 21 2011 434 440